این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
جمعه 24 بهمن 1404
Medical Journal of Islamic Republic of Iran
، جلد ۱۹، شماره ۱، صفحات ۷-۱۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
A MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF HEBER ON (INTERFERON ALFA-2b) IN COMBINATION WITH RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C IN IRAN
چکیده انگلیسی مقاله
ABSTRACT Background: Combination therapy with interferon and ribavirin is the most effective treatment for chronic hepatitis C today. The aim of this study was to evaluate the efficacy and safety of thrice-weekly Heberon (interferon alfa-2b) in combination with ribavirin as first -line treatment of chronic hepatitis C. Methods: A total of97 treatment-naive patients received Heberon three million units thrice-weekly subcutaneously in combination with ribavirin for 12 months. Serum HCV RNA levels were measured before and during therapy and 6 months after the end of therapy. End-of-treatment and sustained virological responses was defmed as an undetectable HCV-RNA level at the end of treatment, and 6 months after treatment was completed (end of follow-up), respectively. Results: In an intent-to-treat analysis, HCV-RNA was undetectable at the end of treatment in 49.5% of patients. At the end of follow-up, sustained virological response was 36.1 %. Combination treatment was generally well tolerated. Six patients stopped therapy because of side effects: severe cytopenia (n=4), depression (n=1), and hyperthyroidism (n= 1 ). Common side effects of therapy include: Flu-like syndrome (85.6%), generalized alopecia (41.2% ), injection site inflammation (37.1% ), mood changes (36% ), anorexia (34%) and weight loss (32% ). Conclusion: Heberon as an IFN product in combination with ribavirin for treat-ment of patients with chronic hepatitis Cis relatively safe, feasible, and potentially efficacious. It has comparable results in achieving end-of-treatment and sustained virological responses in chronic hepatitis C.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
h فروتن | h. forootan
digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
a شریفی | a. sharifi
digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
sh دکتر شهرام میرمومن | sh. mirmomen
digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
n دریانی | n. daryani
digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
h غفرانی | h. ghofrani
digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
m فره وش | m. farahvash
digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
m نصیری | m. nasiri
digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
m طالبی | m. talebi
department of gastroenterology and hepatology, esfahan university of medical sciences,alzahra hospital, esfahan
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی اصفهان (Isfahan university of medical sciences)
a قویدل | a. ghavidel
department of gastroenterology and hepatology, tabriz university of medical sciences, imam khomeini hospital, tabriz.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
h وثوقی نیا | h. vosoghinia
department of internal medicine, mashhad,university of medical sciences, ghaem hospital, mashuniversity of medical sciences, ghaem hospital, university of medical sciences, ghaem hospital, mashhad.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی مشهد (Mashhad university of medical sciences)
f منصورقناعی | f. mansourghanaei
university of medical sciences, razi hospital, rasht.
m زاهدی | m. zahedi
samenolhojaj therapeutic center, kerman.
h دکتر شهرام میرمومن | h. mirmomen
department of internal medicine, ahvaz university of medical sciences, sina hospital, ahvaz.
m عزمی | m. azmi
department of internal medicine, ahvaz university of medical sciences, sina hospital, ahvaz.
m امیریان | m. amirian
department of internal medicine, zahedan university of medical sciences, emam khomeini hospital,zahedan, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی زاهدان (Zahedan university of medical sciences)
نشانی اینترنتی
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-253&slc_lang=en&sid=en
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات